
    
      The study had three groups: Group A: HRV + OPV + DTPa/Hib; Group B: HRV + placebo OPV +
      DTPa-IPV/Hib; Group C: HRV Placebo + OPV + DTPa/Hib. Two cohorts: Subjects enrolled before
      the 2002 RV season were to receive two doses of HRV or placebo at approximately 6 and 10
      weeks of age (first cohort) and subjects enrolled after the 2002 RV season received
      vaccinations at approximately 10 and 14 weeks of age (second cohort). Routine EPI
      vaccinations were to be administered concomitantly with the study vaccines.
    
  